Octreotide

Description

This page contains brief details about the drug octreotide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Octreotide has been approved to treat acromegaly by the U.S. FDA approved on June 26, 2020.

Mechanism of Action of Octreotide

Somatostatin is a hormone produced by the body on its own. It reduces or stops the production of several hormones, including insulin and gut hormones, and it also regulates the stomach and intestinal emptying.

Octreotide is a somatostatin analog that is made synthetically and slows down hormone production. It helps ease carcinoid syndrome, a type of cancer called carcinoid tumors that release certain chemicals into your bloodstream and slows the spread of the tumor. Flushing of the skin, diarrhea, and stomach pain are a few of the symptoms of carcinoid syndrome you could experience.

Uses of Octreotide

Octreotide treats acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors (VIPoma).

Octreotide Dosage available

Octreotide is available as an immediate-release solution (liquid) for injection in the doses of 10 mg, 20 mg, and 30 mg. It is intended for administration via the subcutaneous or intravenous route. It must be administered only under the supervision of a healthcare professional at around the same time every day. Check for discoloration and the presence of particles before injecting.